Sayamba, Analyn L.

HRN: 10-92-88  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
CEFUROXIME 1.5GM (VIAL)
06/19/2026
06/20/2026
IVTT
1.5g
Q12h
UTI Following Delivery
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: